Global Primary CD56+ NK Cells Supply, Demand and Key Producers, 2023-2029
The global Primary CD56+ NK Cells market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Primary CD56+ Natural killer (NK) cells are the major effectors of the innate immune system and are important in host defense, cancer, and autoimmunity. CD56+ Natural Killer Cells are isolated from mononuclear cells by negative selection using immunomagnetic cell separation procedures.
This report studies the global Primary CD56+ NK Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Primary CD56+ NK Cells, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Primary CD56+ NK Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Primary CD56+ NK Cells total production and demand, 2018-2029, (K Units)
Global Primary CD56+ NK Cells total production value, 2018-2029, (USD Million)
Global Primary CD56+ NK Cells production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Primary CD56+ NK Cells consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Primary CD56+ NK Cells domestic production, consumption, key domestic manufacturers and share
Global Primary CD56+ NK Cells production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Primary CD56+ NK Cells production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Primary CD56+ NK Cells production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Primary CD56+ NK Cells market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PBM, ATCC, STEMCEITM, Thermo Fisher Scientific, AllCells, ABM, 3H Biomedical, ProMab Biotechnologies and AcceGen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Primary CD56+ NK Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Primary CD56+ NK Cells Market, By Region:
1. How big is the global Primary CD56+ NK Cells market?
2. What is the demand of the global Primary CD56+ NK Cells market?
3. What is the year over year growth of the global Primary CD56+ NK Cells market?
4. What is the production and production value of the global Primary CD56+ NK Cells market?
5. Who are the key producers in the global Primary CD56+ NK Cells market?
6. What are the growth factors driving the market demand?
Primary CD56+ Natural killer (NK) cells are the major effectors of the innate immune system and are important in host defense, cancer, and autoimmunity. CD56+ Natural Killer Cells are isolated from mononuclear cells by negative selection using immunomagnetic cell separation procedures.
This report studies the global Primary CD56+ NK Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Primary CD56+ NK Cells, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Primary CD56+ NK Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Primary CD56+ NK Cells total production and demand, 2018-2029, (K Units)
Global Primary CD56+ NK Cells total production value, 2018-2029, (USD Million)
Global Primary CD56+ NK Cells production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Primary CD56+ NK Cells consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Primary CD56+ NK Cells domestic production, consumption, key domestic manufacturers and share
Global Primary CD56+ NK Cells production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Primary CD56+ NK Cells production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Primary CD56+ NK Cells production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Primary CD56+ NK Cells market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PBM, ATCC, STEMCEITM, Thermo Fisher Scientific, AllCells, ABM, 3H Biomedical, ProMab Biotechnologies and AcceGen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Primary CD56+ NK Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Primary CD56+ NK Cells Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Custom Made
- Bulk
- Compound Screening
- Immune Function Assay
- Drug Discovery
- Others
- PBM
- ATCC
- STEMCEITM
- Thermo Fisher Scientific
- AllCells
- ABM
- 3H Biomedical
- ProMab Biotechnologies
- AcceGen
- AMSBIO
- Clinisciences
- Creative Bioarray
- iCell Bioscience
- Shenzhen Kingfocus Biomedical
1. How big is the global Primary CD56+ NK Cells market?
2. What is the demand of the global Primary CD56+ NK Cells market?
3. What is the year over year growth of the global Primary CD56+ NK Cells market?
4. What is the production and production value of the global Primary CD56+ NK Cells market?
5. Who are the key producers in the global Primary CD56+ NK Cells market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Primary CD56+ NK Cells Introduction
1.2 World Primary CD56+ NK Cells Supply & Forecast
1.2.1 World Primary CD56+ NK Cells Production Value (2018 & 2022 & 2029)
1.2.2 World Primary CD56+ NK Cells Production (2018-2029)
1.2.3 World Primary CD56+ NK Cells Pricing Trends (2018-2029)
1.3 World Primary CD56+ NK Cells Production by Region (Based on Production Site)
1.3.1 World Primary CD56+ NK Cells Production Value by Region (2018-2029)
1.3.2 World Primary CD56+ NK Cells Production by Region (2018-2029)
1.3.3 World Primary CD56+ NK Cells Average Price by Region (2018-2029)
1.3.4 North America Primary CD56+ NK Cells Production (2018-2029)
1.3.5 Europe Primary CD56+ NK Cells Production (2018-2029)
1.3.6 China Primary CD56+ NK Cells Production (2018-2029)
1.3.7 Japan Primary CD56+ NK Cells Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Primary CD56+ NK Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Primary CD56+ NK Cells Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Primary CD56+ NK Cells Demand (2018-2029)
2.2 World Primary CD56+ NK Cells Consumption by Region
2.2.1 World Primary CD56+ NK Cells Consumption by Region (2018-2023)
2.2.2 World Primary CD56+ NK Cells Consumption Forecast by Region (2024-2029)
2.3 United States Primary CD56+ NK Cells Consumption (2018-2029)
2.4 China Primary CD56+ NK Cells Consumption (2018-2029)
2.5 Europe Primary CD56+ NK Cells Consumption (2018-2029)
2.6 Japan Primary CD56+ NK Cells Consumption (2018-2029)
2.7 South Korea Primary CD56+ NK Cells Consumption (2018-2029)
2.8 ASEAN Primary CD56+ NK Cells Consumption (2018-2029)
2.9 India Primary CD56+ NK Cells Consumption (2018-2029)
3 WORLD PRIMARY CD56+ NK CELLS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Primary CD56+ NK Cells Production Value by Manufacturer (2018-2023)
3.2 World Primary CD56+ NK Cells Production by Manufacturer (2018-2023)
3.3 World Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023)
3.4 Primary CD56+ NK Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Primary CD56+ NK Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Primary CD56+ NK Cells in 2022
3.5.3 Global Concentration Ratios (CR8) for Primary CD56+ NK Cells in 2022
3.6 Primary CD56+ NK Cells Market: Overall Company Footprint Analysis
3.6.1 Primary CD56+ NK Cells Market: Region Footprint
3.6.2 Primary CD56+ NK Cells Market: Company Product Type Footprint
3.6.3 Primary CD56+ NK Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Primary CD56+ NK Cells Production Value Comparison
4.1.1 United States VS China: Primary CD56+ NK Cells Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Primary CD56+ NK Cells Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Primary CD56+ NK Cells Production Comparison
4.2.1 United States VS China: Primary CD56+ NK Cells Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Primary CD56+ NK Cells Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Primary CD56+ NK Cells Consumption Comparison
4.3.1 United States VS China: Primary CD56+ NK Cells Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Primary CD56+ NK Cells Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Primary CD56+ NK Cells Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.4.3 United States Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
4.5 China Based Primary CD56+ NK Cells Manufacturers and Market Share
4.5.1 China Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.5.3 China Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
4.6 Rest of World Based Primary CD56+ NK Cells Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Primary CD56+ NK Cells Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Custom Made
5.2.2 Bulk
5.3 Market Segment by Type
5.3.1 World Primary CD56+ NK Cells Production by Type (2018-2029)
5.3.2 World Primary CD56+ NK Cells Production Value by Type (2018-2029)
5.3.3 World Primary CD56+ NK Cells Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Primary CD56+ NK Cells Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Compound Screening
6.2.2 Immune Function Assay
6.2.3 Drug Discovery
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Primary CD56+ NK Cells Production by Application (2018-2029)
6.3.2 World Primary CD56+ NK Cells Production Value by Application (2018-2029)
6.3.3 World Primary CD56+ NK Cells Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 PBM
7.1.1 PBM Details
7.1.2 PBM Major Business
7.1.3 PBM Primary CD56+ NK Cells Product and Services
7.1.4 PBM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 PBM Recent Developments/Updates
7.1.6 PBM Competitive Strengths & Weaknesses
7.2 ATCC
7.2.1 ATCC Details
7.2.2 ATCC Major Business
7.2.3 ATCC Primary CD56+ NK Cells Product and Services
7.2.4 ATCC Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 ATCC Recent Developments/Updates
7.2.6 ATCC Competitive Strengths & Weaknesses
7.3 STEMCEITM
7.3.1 STEMCEITM Details
7.3.2 STEMCEITM Major Business
7.3.3 STEMCEITM Primary CD56+ NK Cells Product and Services
7.3.4 STEMCEITM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 STEMCEITM Recent Developments/Updates
7.3.6 STEMCEITM Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
7.4.4 Thermo Fisher Scientific Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 AllCells
7.5.1 AllCells Details
7.5.2 AllCells Major Business
7.5.3 AllCells Primary CD56+ NK Cells Product and Services
7.5.4 AllCells Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AllCells Recent Developments/Updates
7.5.6 AllCells Competitive Strengths & Weaknesses
7.6 ABM
7.6.1 ABM Details
7.6.2 ABM Major Business
7.6.3 ABM Primary CD56+ NK Cells Product and Services
7.6.4 ABM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 ABM Recent Developments/Updates
7.6.6 ABM Competitive Strengths & Weaknesses
7.7 3H Biomedical
7.7.1 3H Biomedical Details
7.7.2 3H Biomedical Major Business
7.7.3 3H Biomedical Primary CD56+ NK Cells Product and Services
7.7.4 3H Biomedical Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 3H Biomedical Recent Developments/Updates
7.7.6 3H Biomedical Competitive Strengths & Weaknesses
7.8 ProMab Biotechnologies
7.8.1 ProMab Biotechnologies Details
7.8.2 ProMab Biotechnologies Major Business
7.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
7.8.4 ProMab Biotechnologies Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ProMab Biotechnologies Recent Developments/Updates
7.8.6 ProMab Biotechnologies Competitive Strengths & Weaknesses
7.9 AcceGen
7.9.1 AcceGen Details
7.9.2 AcceGen Major Business
7.9.3 AcceGen Primary CD56+ NK Cells Product and Services
7.9.4 AcceGen Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AcceGen Recent Developments/Updates
7.9.6 AcceGen Competitive Strengths & Weaknesses
7.10 AMSBIO
7.10.1 AMSBIO Details
7.10.2 AMSBIO Major Business
7.10.3 AMSBIO Primary CD56+ NK Cells Product and Services
7.10.4 AMSBIO Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 AMSBIO Recent Developments/Updates
7.10.6 AMSBIO Competitive Strengths & Weaknesses
7.11 Clinisciences
7.11.1 Clinisciences Details
7.11.2 Clinisciences Major Business
7.11.3 Clinisciences Primary CD56+ NK Cells Product and Services
7.11.4 Clinisciences Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Clinisciences Recent Developments/Updates
7.11.6 Clinisciences Competitive Strengths & Weaknesses
7.12 Creative Bioarray
7.12.1 Creative Bioarray Details
7.12.2 Creative Bioarray Major Business
7.12.3 Creative Bioarray Primary CD56+ NK Cells Product and Services
7.12.4 Creative Bioarray Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Creative Bioarray Recent Developments/Updates
7.12.6 Creative Bioarray Competitive Strengths & Weaknesses
7.13 iCell Bioscience
7.13.1 iCell Bioscience Details
7.13.2 iCell Bioscience Major Business
7.13.3 iCell Bioscience Primary CD56+ NK Cells Product and Services
7.13.4 iCell Bioscience Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 iCell Bioscience Recent Developments/Updates
7.13.6 iCell Bioscience Competitive Strengths & Weaknesses
7.14 Shenzhen Kingfocus Biomedical
7.14.1 Shenzhen Kingfocus Biomedical Details
7.14.2 Shenzhen Kingfocus Biomedical Major Business
7.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
7.14.4 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shenzhen Kingfocus Biomedical Recent Developments/Updates
7.14.6 Shenzhen Kingfocus Biomedical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Primary CD56+ NK Cells Industry Chain
8.2 Primary CD56+ NK Cells Upstream Analysis
8.2.1 Primary CD56+ NK Cells Core Raw Materials
8.2.2 Main Manufacturers of Primary CD56+ NK Cells Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Primary CD56+ NK Cells Production Mode
8.6 Primary CD56+ NK Cells Procurement Model
8.7 Primary CD56+ NK Cells Industry Sales Model and Sales Channels
8.7.1 Primary CD56+ NK Cells Sales Model
8.7.2 Primary CD56+ NK Cells Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Primary CD56+ NK Cells Introduction
1.2 World Primary CD56+ NK Cells Supply & Forecast
1.2.1 World Primary CD56+ NK Cells Production Value (2018 & 2022 & 2029)
1.2.2 World Primary CD56+ NK Cells Production (2018-2029)
1.2.3 World Primary CD56+ NK Cells Pricing Trends (2018-2029)
1.3 World Primary CD56+ NK Cells Production by Region (Based on Production Site)
1.3.1 World Primary CD56+ NK Cells Production Value by Region (2018-2029)
1.3.2 World Primary CD56+ NK Cells Production by Region (2018-2029)
1.3.3 World Primary CD56+ NK Cells Average Price by Region (2018-2029)
1.3.4 North America Primary CD56+ NK Cells Production (2018-2029)
1.3.5 Europe Primary CD56+ NK Cells Production (2018-2029)
1.3.6 China Primary CD56+ NK Cells Production (2018-2029)
1.3.7 Japan Primary CD56+ NK Cells Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Primary CD56+ NK Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Primary CD56+ NK Cells Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Primary CD56+ NK Cells Demand (2018-2029)
2.2 World Primary CD56+ NK Cells Consumption by Region
2.2.1 World Primary CD56+ NK Cells Consumption by Region (2018-2023)
2.2.2 World Primary CD56+ NK Cells Consumption Forecast by Region (2024-2029)
2.3 United States Primary CD56+ NK Cells Consumption (2018-2029)
2.4 China Primary CD56+ NK Cells Consumption (2018-2029)
2.5 Europe Primary CD56+ NK Cells Consumption (2018-2029)
2.6 Japan Primary CD56+ NK Cells Consumption (2018-2029)
2.7 South Korea Primary CD56+ NK Cells Consumption (2018-2029)
2.8 ASEAN Primary CD56+ NK Cells Consumption (2018-2029)
2.9 India Primary CD56+ NK Cells Consumption (2018-2029)
3 WORLD PRIMARY CD56+ NK CELLS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Primary CD56+ NK Cells Production Value by Manufacturer (2018-2023)
3.2 World Primary CD56+ NK Cells Production by Manufacturer (2018-2023)
3.3 World Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023)
3.4 Primary CD56+ NK Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Primary CD56+ NK Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Primary CD56+ NK Cells in 2022
3.5.3 Global Concentration Ratios (CR8) for Primary CD56+ NK Cells in 2022
3.6 Primary CD56+ NK Cells Market: Overall Company Footprint Analysis
3.6.1 Primary CD56+ NK Cells Market: Region Footprint
3.6.2 Primary CD56+ NK Cells Market: Company Product Type Footprint
3.6.3 Primary CD56+ NK Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Primary CD56+ NK Cells Production Value Comparison
4.1.1 United States VS China: Primary CD56+ NK Cells Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Primary CD56+ NK Cells Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Primary CD56+ NK Cells Production Comparison
4.2.1 United States VS China: Primary CD56+ NK Cells Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Primary CD56+ NK Cells Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Primary CD56+ NK Cells Consumption Comparison
4.3.1 United States VS China: Primary CD56+ NK Cells Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Primary CD56+ NK Cells Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Primary CD56+ NK Cells Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.4.3 United States Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
4.5 China Based Primary CD56+ NK Cells Manufacturers and Market Share
4.5.1 China Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.5.3 China Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
4.6 Rest of World Based Primary CD56+ NK Cells Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Primary CD56+ NK Cells Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Primary CD56+ NK Cells Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Custom Made
5.2.2 Bulk
5.3 Market Segment by Type
5.3.1 World Primary CD56+ NK Cells Production by Type (2018-2029)
5.3.2 World Primary CD56+ NK Cells Production Value by Type (2018-2029)
5.3.3 World Primary CD56+ NK Cells Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Primary CD56+ NK Cells Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Compound Screening
6.2.2 Immune Function Assay
6.2.3 Drug Discovery
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Primary CD56+ NK Cells Production by Application (2018-2029)
6.3.2 World Primary CD56+ NK Cells Production Value by Application (2018-2029)
6.3.3 World Primary CD56+ NK Cells Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 PBM
7.1.1 PBM Details
7.1.2 PBM Major Business
7.1.3 PBM Primary CD56+ NK Cells Product and Services
7.1.4 PBM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 PBM Recent Developments/Updates
7.1.6 PBM Competitive Strengths & Weaknesses
7.2 ATCC
7.2.1 ATCC Details
7.2.2 ATCC Major Business
7.2.3 ATCC Primary CD56+ NK Cells Product and Services
7.2.4 ATCC Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 ATCC Recent Developments/Updates
7.2.6 ATCC Competitive Strengths & Weaknesses
7.3 STEMCEITM
7.3.1 STEMCEITM Details
7.3.2 STEMCEITM Major Business
7.3.3 STEMCEITM Primary CD56+ NK Cells Product and Services
7.3.4 STEMCEITM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 STEMCEITM Recent Developments/Updates
7.3.6 STEMCEITM Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
7.4.4 Thermo Fisher Scientific Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 AllCells
7.5.1 AllCells Details
7.5.2 AllCells Major Business
7.5.3 AllCells Primary CD56+ NK Cells Product and Services
7.5.4 AllCells Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AllCells Recent Developments/Updates
7.5.6 AllCells Competitive Strengths & Weaknesses
7.6 ABM
7.6.1 ABM Details
7.6.2 ABM Major Business
7.6.3 ABM Primary CD56+ NK Cells Product and Services
7.6.4 ABM Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 ABM Recent Developments/Updates
7.6.6 ABM Competitive Strengths & Weaknesses
7.7 3H Biomedical
7.7.1 3H Biomedical Details
7.7.2 3H Biomedical Major Business
7.7.3 3H Biomedical Primary CD56+ NK Cells Product and Services
7.7.4 3H Biomedical Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 3H Biomedical Recent Developments/Updates
7.7.6 3H Biomedical Competitive Strengths & Weaknesses
7.8 ProMab Biotechnologies
7.8.1 ProMab Biotechnologies Details
7.8.2 ProMab Biotechnologies Major Business
7.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
7.8.4 ProMab Biotechnologies Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 ProMab Biotechnologies Recent Developments/Updates
7.8.6 ProMab Biotechnologies Competitive Strengths & Weaknesses
7.9 AcceGen
7.9.1 AcceGen Details
7.9.2 AcceGen Major Business
7.9.3 AcceGen Primary CD56+ NK Cells Product and Services
7.9.4 AcceGen Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AcceGen Recent Developments/Updates
7.9.6 AcceGen Competitive Strengths & Weaknesses
7.10 AMSBIO
7.10.1 AMSBIO Details
7.10.2 AMSBIO Major Business
7.10.3 AMSBIO Primary CD56+ NK Cells Product and Services
7.10.4 AMSBIO Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 AMSBIO Recent Developments/Updates
7.10.6 AMSBIO Competitive Strengths & Weaknesses
7.11 Clinisciences
7.11.1 Clinisciences Details
7.11.2 Clinisciences Major Business
7.11.3 Clinisciences Primary CD56+ NK Cells Product and Services
7.11.4 Clinisciences Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Clinisciences Recent Developments/Updates
7.11.6 Clinisciences Competitive Strengths & Weaknesses
7.12 Creative Bioarray
7.12.1 Creative Bioarray Details
7.12.2 Creative Bioarray Major Business
7.12.3 Creative Bioarray Primary CD56+ NK Cells Product and Services
7.12.4 Creative Bioarray Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Creative Bioarray Recent Developments/Updates
7.12.6 Creative Bioarray Competitive Strengths & Weaknesses
7.13 iCell Bioscience
7.13.1 iCell Bioscience Details
7.13.2 iCell Bioscience Major Business
7.13.3 iCell Bioscience Primary CD56+ NK Cells Product and Services
7.13.4 iCell Bioscience Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 iCell Bioscience Recent Developments/Updates
7.13.6 iCell Bioscience Competitive Strengths & Weaknesses
7.14 Shenzhen Kingfocus Biomedical
7.14.1 Shenzhen Kingfocus Biomedical Details
7.14.2 Shenzhen Kingfocus Biomedical Major Business
7.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
7.14.4 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shenzhen Kingfocus Biomedical Recent Developments/Updates
7.14.6 Shenzhen Kingfocus Biomedical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Primary CD56+ NK Cells Industry Chain
8.2 Primary CD56+ NK Cells Upstream Analysis
8.2.1 Primary CD56+ NK Cells Core Raw Materials
8.2.2 Main Manufacturers of Primary CD56+ NK Cells Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Primary CD56+ NK Cells Production Mode
8.6 Primary CD56+ NK Cells Procurement Model
8.7 Primary CD56+ NK Cells Industry Sales Model and Sales Channels
8.7.1 Primary CD56+ NK Cells Sales Model
8.7.2 Primary CD56+ NK Cells Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Primary CD56+ NK Cells Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Primary CD56+ NK Cells Production Value by Region (2018-2023) & (USD Million)
Table 3. World Primary CD56+ NK Cells Production Value by Region (2024-2029) & (USD Million)
Table 4. World Primary CD56+ NK Cells Production Value Market Share by Region (2018-2023)
Table 5. World Primary CD56+ NK Cells Production Value Market Share by Region (2024-2029)
Table 6. World Primary CD56+ NK Cells Production by Region (2018-2023) & (K Units)
Table 7. World Primary CD56+ NK Cells Production by Region (2024-2029) & (K Units)
Table 8. World Primary CD56+ NK Cells Production Market Share by Region (2018-2023)
Table 9. World Primary CD56+ NK Cells Production Market Share by Region (2024-2029)
Table 10. World Primary CD56+ NK Cells Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Primary CD56+ NK Cells Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Primary CD56+ NK Cells Major Market Trends
Table 13. World Primary CD56+ NK Cells Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Primary CD56+ NK Cells Consumption by Region (2018-2023) & (K Units)
Table 15. World Primary CD56+ NK Cells Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Primary CD56+ NK Cells Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Primary CD56+ NK Cells Producers in 2022
Table 18. World Primary CD56+ NK Cells Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Primary CD56+ NK Cells Producers in 2022
Table 20. World Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Primary CD56+ NK Cells Company Evaluation Quadrant
Table 22. World Primary CD56+ NK Cells Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 24. Primary CD56+ NK Cells Market: Company Product Type Footprint
Table 25. Primary CD56+ NK Cells Market: Company Product Application Footprint
Table 26. Primary CD56+ NK Cells Competitive Factors
Table 27. Primary CD56+ NK Cells New Entrant and Capacity Expansion Plans
Table 28. Primary CD56+ NK Cells Mergers & Acquisitions Activity
Table 29. United States VS China Primary CD56+ NK Cells Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Primary CD56+ NK Cells Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Primary CD56+ NK Cells Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 37. China Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 42. Rest of World Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 47. World Primary CD56+ NK Cells Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Primary CD56+ NK Cells Production by Type (2018-2023) & (K Units)
Table 49. World Primary CD56+ NK Cells Production by Type (2024-2029) & (K Units)
Table 50. World Primary CD56+ NK Cells Production Value by Type (2018-2023) & (USD Million)
Table 51. World Primary CD56+ NK Cells Production Value by Type (2024-2029) & (USD Million)
Table 52. World Primary CD56+ NK Cells Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Primary CD56+ NK Cells Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Primary CD56+ NK Cells Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Primary CD56+ NK Cells Production by Application (2018-2023) & (K Units)
Table 56. World Primary CD56+ NK Cells Production by Application (2024-2029) & (K Units)
Table 57. World Primary CD56+ NK Cells Production Value by Application (2018-2023) & (USD Million)
Table 58. World Primary CD56+ NK Cells Production Value by Application (2024-2029) & (USD Million)
Table 59. World Primary CD56+ NK Cells Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Primary CD56+ NK Cells Average Price by Application (2024-2029) & (US$/Unit)
Table 61. PBM Basic Information, Manufacturing Base and Competitors
Table 62. PBM Major Business
Table 63. PBM Primary CD56+ NK Cells Product and Services
Table 64. PBM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. PBM Recent Developments/Updates
Table 66. PBM Competitive Strengths & Weaknesses
Table 67. ATCC Basic Information, Manufacturing Base and Competitors
Table 68. ATCC Major Business
Table 69. ATCC Primary CD56+ NK Cells Product and Services
Table 70. ATCC Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. ATCC Recent Developments/Updates
Table 72. ATCC Competitive Strengths & Weaknesses
Table 73. STEMCEITM Basic Information, Manufacturing Base and Competitors
Table 74. STEMCEITM Major Business
Table 75. STEMCEITM Primary CD56+ NK Cells Product and Services
Table 76. STEMCEITM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. STEMCEITM Recent Developments/Updates
Table 78. STEMCEITM Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
Table 82. Thermo Fisher Scientific Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. AllCells Basic Information, Manufacturing Base and Competitors
Table 86. AllCells Major Business
Table 87. AllCells Primary CD56+ NK Cells Product and Services
Table 88. AllCells Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AllCells Recent Developments/Updates
Table 90. AllCells Competitive Strengths & Weaknesses
Table 91. ABM Basic Information, Manufacturing Base and Competitors
Table 92. ABM Major Business
Table 93. ABM Primary CD56+ NK Cells Product and Services
Table 94. ABM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. ABM Recent Developments/Updates
Table 96. ABM Competitive Strengths & Weaknesses
Table 97. 3H Biomedical Basic Information, Manufacturing Base and Competitors
Table 98. 3H Biomedical Major Business
Table 99. 3H Biomedical Primary CD56+ NK Cells Product and Services
Table 100. 3H Biomedical Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. 3H Biomedical Recent Developments/Updates
Table 102. 3H Biomedical Competitive Strengths & Weaknesses
Table 103. ProMab Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 104. ProMab Biotechnologies Major Business
Table 105. ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
Table 106. ProMab Biotechnologies Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ProMab Biotechnologies Recent Developments/Updates
Table 108. ProMab Biotechnologies Competitive Strengths & Weaknesses
Table 109. AcceGen Basic Information, Manufacturing Base and Competitors
Table 110. AcceGen Major Business
Table 111. AcceGen Primary CD56+ NK Cells Product and Services
Table 112. AcceGen Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AcceGen Recent Developments/Updates
Table 114. AcceGen Competitive Strengths & Weaknesses
Table 115. AMSBIO Basic Information, Manufacturing Base and Competitors
Table 116. AMSBIO Major Business
Table 117. AMSBIO Primary CD56+ NK Cells Product and Services
Table 118. AMSBIO Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. AMSBIO Recent Developments/Updates
Table 120. AMSBIO Competitive Strengths & Weaknesses
Table 121. Clinisciences Basic Information, Manufacturing Base and Competitors
Table 122. Clinisciences Major Business
Table 123. Clinisciences Primary CD56+ NK Cells Product and Services
Table 124. Clinisciences Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Clinisciences Recent Developments/Updates
Table 126. Clinisciences Competitive Strengths & Weaknesses
Table 127. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 128. Creative Bioarray Major Business
Table 129. Creative Bioarray Primary CD56+ NK Cells Product and Services
Table 130. Creative Bioarray Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Creative Bioarray Recent Developments/Updates
Table 132. Creative Bioarray Competitive Strengths & Weaknesses
Table 133. iCell Bioscience Basic Information, Manufacturing Base and Competitors
Table 134. iCell Bioscience Major Business
Table 135. iCell Bioscience Primary CD56+ NK Cells Product and Services
Table 136. iCell Bioscience Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. iCell Bioscience Recent Developments/Updates
Table 138. Shenzhen Kingfocus Biomedical Basic Information, Manufacturing Base and Competitors
Table 139. Shenzhen Kingfocus Biomedical Major Business
Table 140. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
Table 141. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Primary CD56+ NK Cells Upstream (Raw Materials)
Table 143. Primary CD56+ NK Cells Typical Customers
Table 144. Primary CD56+ NK Cells Typical Distributors
Table 1. World Primary CD56+ NK Cells Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Primary CD56+ NK Cells Production Value by Region (2018-2023) & (USD Million)
Table 3. World Primary CD56+ NK Cells Production Value by Region (2024-2029) & (USD Million)
Table 4. World Primary CD56+ NK Cells Production Value Market Share by Region (2018-2023)
Table 5. World Primary CD56+ NK Cells Production Value Market Share by Region (2024-2029)
Table 6. World Primary CD56+ NK Cells Production by Region (2018-2023) & (K Units)
Table 7. World Primary CD56+ NK Cells Production by Region (2024-2029) & (K Units)
Table 8. World Primary CD56+ NK Cells Production Market Share by Region (2018-2023)
Table 9. World Primary CD56+ NK Cells Production Market Share by Region (2024-2029)
Table 10. World Primary CD56+ NK Cells Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Primary CD56+ NK Cells Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Primary CD56+ NK Cells Major Market Trends
Table 13. World Primary CD56+ NK Cells Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Primary CD56+ NK Cells Consumption by Region (2018-2023) & (K Units)
Table 15. World Primary CD56+ NK Cells Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Primary CD56+ NK Cells Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Primary CD56+ NK Cells Producers in 2022
Table 18. World Primary CD56+ NK Cells Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Primary CD56+ NK Cells Producers in 2022
Table 20. World Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Primary CD56+ NK Cells Company Evaluation Quadrant
Table 22. World Primary CD56+ NK Cells Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 24. Primary CD56+ NK Cells Market: Company Product Type Footprint
Table 25. Primary CD56+ NK Cells Market: Company Product Application Footprint
Table 26. Primary CD56+ NK Cells Competitive Factors
Table 27. Primary CD56+ NK Cells New Entrant and Capacity Expansion Plans
Table 28. Primary CD56+ NK Cells Mergers & Acquisitions Activity
Table 29. United States VS China Primary CD56+ NK Cells Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Primary CD56+ NK Cells Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Primary CD56+ NK Cells Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 37. China Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 42. Rest of World Based Primary CD56+ NK Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Primary CD56+ NK Cells Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Market Share (2018-2023)
Table 47. World Primary CD56+ NK Cells Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Primary CD56+ NK Cells Production by Type (2018-2023) & (K Units)
Table 49. World Primary CD56+ NK Cells Production by Type (2024-2029) & (K Units)
Table 50. World Primary CD56+ NK Cells Production Value by Type (2018-2023) & (USD Million)
Table 51. World Primary CD56+ NK Cells Production Value by Type (2024-2029) & (USD Million)
Table 52. World Primary CD56+ NK Cells Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Primary CD56+ NK Cells Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Primary CD56+ NK Cells Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Primary CD56+ NK Cells Production by Application (2018-2023) & (K Units)
Table 56. World Primary CD56+ NK Cells Production by Application (2024-2029) & (K Units)
Table 57. World Primary CD56+ NK Cells Production Value by Application (2018-2023) & (USD Million)
Table 58. World Primary CD56+ NK Cells Production Value by Application (2024-2029) & (USD Million)
Table 59. World Primary CD56+ NK Cells Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Primary CD56+ NK Cells Average Price by Application (2024-2029) & (US$/Unit)
Table 61. PBM Basic Information, Manufacturing Base and Competitors
Table 62. PBM Major Business
Table 63. PBM Primary CD56+ NK Cells Product and Services
Table 64. PBM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. PBM Recent Developments/Updates
Table 66. PBM Competitive Strengths & Weaknesses
Table 67. ATCC Basic Information, Manufacturing Base and Competitors
Table 68. ATCC Major Business
Table 69. ATCC Primary CD56+ NK Cells Product and Services
Table 70. ATCC Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. ATCC Recent Developments/Updates
Table 72. ATCC Competitive Strengths & Weaknesses
Table 73. STEMCEITM Basic Information, Manufacturing Base and Competitors
Table 74. STEMCEITM Major Business
Table 75. STEMCEITM Primary CD56+ NK Cells Product and Services
Table 76. STEMCEITM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. STEMCEITM Recent Developments/Updates
Table 78. STEMCEITM Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
Table 82. Thermo Fisher Scientific Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. AllCells Basic Information, Manufacturing Base and Competitors
Table 86. AllCells Major Business
Table 87. AllCells Primary CD56+ NK Cells Product and Services
Table 88. AllCells Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AllCells Recent Developments/Updates
Table 90. AllCells Competitive Strengths & Weaknesses
Table 91. ABM Basic Information, Manufacturing Base and Competitors
Table 92. ABM Major Business
Table 93. ABM Primary CD56+ NK Cells Product and Services
Table 94. ABM Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. ABM Recent Developments/Updates
Table 96. ABM Competitive Strengths & Weaknesses
Table 97. 3H Biomedical Basic Information, Manufacturing Base and Competitors
Table 98. 3H Biomedical Major Business
Table 99. 3H Biomedical Primary CD56+ NK Cells Product and Services
Table 100. 3H Biomedical Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. 3H Biomedical Recent Developments/Updates
Table 102. 3H Biomedical Competitive Strengths & Weaknesses
Table 103. ProMab Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 104. ProMab Biotechnologies Major Business
Table 105. ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
Table 106. ProMab Biotechnologies Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. ProMab Biotechnologies Recent Developments/Updates
Table 108. ProMab Biotechnologies Competitive Strengths & Weaknesses
Table 109. AcceGen Basic Information, Manufacturing Base and Competitors
Table 110. AcceGen Major Business
Table 111. AcceGen Primary CD56+ NK Cells Product and Services
Table 112. AcceGen Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AcceGen Recent Developments/Updates
Table 114. AcceGen Competitive Strengths & Weaknesses
Table 115. AMSBIO Basic Information, Manufacturing Base and Competitors
Table 116. AMSBIO Major Business
Table 117. AMSBIO Primary CD56+ NK Cells Product and Services
Table 118. AMSBIO Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. AMSBIO Recent Developments/Updates
Table 120. AMSBIO Competitive Strengths & Weaknesses
Table 121. Clinisciences Basic Information, Manufacturing Base and Competitors
Table 122. Clinisciences Major Business
Table 123. Clinisciences Primary CD56+ NK Cells Product and Services
Table 124. Clinisciences Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Clinisciences Recent Developments/Updates
Table 126. Clinisciences Competitive Strengths & Weaknesses
Table 127. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 128. Creative Bioarray Major Business
Table 129. Creative Bioarray Primary CD56+ NK Cells Product and Services
Table 130. Creative Bioarray Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Creative Bioarray Recent Developments/Updates
Table 132. Creative Bioarray Competitive Strengths & Weaknesses
Table 133. iCell Bioscience Basic Information, Manufacturing Base and Competitors
Table 134. iCell Bioscience Major Business
Table 135. iCell Bioscience Primary CD56+ NK Cells Product and Services
Table 136. iCell Bioscience Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. iCell Bioscience Recent Developments/Updates
Table 138. Shenzhen Kingfocus Biomedical Basic Information, Manufacturing Base and Competitors
Table 139. Shenzhen Kingfocus Biomedical Major Business
Table 140. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
Table 141. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Primary CD56+ NK Cells Upstream (Raw Materials)
Table 143. Primary CD56+ NK Cells Typical Customers
Table 144. Primary CD56+ NK Cells Typical Distributors
LIST OF FIGURES
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. World Primary CD56+ NK Cells Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Primary CD56+ NK Cells Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 5. World Primary CD56+ NK Cells Average Price (2018-2029) & (US$/Unit)
Figure 6. World Primary CD56+ NK Cells Production Value Market Share by Region (2018-2029)
Figure 7. World Primary CD56+ NK Cells Production Market Share by Region (2018-2029)
Figure 8. North America Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 9. Europe Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 10. China Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 11. Japan Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 12. Primary CD56+ NK Cells Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 15. World Primary CD56+ NK Cells Consumption Market Share by Region (2018-2029)
Figure 16. United States Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 17. China Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 18. Europe Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 19. Japan Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 20. South Korea Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 22. India Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Primary CD56+ NK Cells by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Primary CD56+ NK Cells Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Primary CD56+ NK Cells Markets in 2022
Figure 26. United States VS China: Primary CD56+ NK Cells Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Primary CD56+ NK Cells Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Primary CD56+ NK Cells Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 30. China Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 32. World Primary CD56+ NK Cells Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Primary CD56+ NK Cells Production Value Market Share by Type in 2022
Figure 34. Custom Made
Figure 35. Bulk
Figure 36. World Primary CD56+ NK Cells Production Market Share by Type (2018-2029)
Figure 37. World Primary CD56+ NK Cells Production Value Market Share by Type (2018-2029)
Figure 38. World Primary CD56+ NK Cells Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Primary CD56+ NK Cells Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Primary CD56+ NK Cells Production Value Market Share by Application in 2022
Figure 41. Compound Screening
Figure 42. Immune Function Assay
Figure 43. Drug Discovery
Figure 44. Others
Figure 45. World Primary CD56+ NK Cells Production Market Share by Application (2018-2029)
Figure 46. World Primary CD56+ NK Cells Production Value Market Share by Application (2018-2029)
Figure 47. World Primary CD56+ NK Cells Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Primary CD56+ NK Cells Industry Chain
Figure 49. Primary CD56+ NK Cells Procurement Model
Figure 50. Primary CD56+ NK Cells Sales Model
Figure 51. Primary CD56+ NK Cells Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. World Primary CD56+ NK Cells Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Primary CD56+ NK Cells Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 5. World Primary CD56+ NK Cells Average Price (2018-2029) & (US$/Unit)
Figure 6. World Primary CD56+ NK Cells Production Value Market Share by Region (2018-2029)
Figure 7. World Primary CD56+ NK Cells Production Market Share by Region (2018-2029)
Figure 8. North America Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 9. Europe Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 10. China Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 11. Japan Primary CD56+ NK Cells Production (2018-2029) & (K Units)
Figure 12. Primary CD56+ NK Cells Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 15. World Primary CD56+ NK Cells Consumption Market Share by Region (2018-2029)
Figure 16. United States Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 17. China Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 18. Europe Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 19. Japan Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 20. South Korea Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 22. India Primary CD56+ NK Cells Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Primary CD56+ NK Cells by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Primary CD56+ NK Cells Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Primary CD56+ NK Cells Markets in 2022
Figure 26. United States VS China: Primary CD56+ NK Cells Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Primary CD56+ NK Cells Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Primary CD56+ NK Cells Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 30. China Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Primary CD56+ NK Cells Production Market Share 2022
Figure 32. World Primary CD56+ NK Cells Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Primary CD56+ NK Cells Production Value Market Share by Type in 2022
Figure 34. Custom Made
Figure 35. Bulk
Figure 36. World Primary CD56+ NK Cells Production Market Share by Type (2018-2029)
Figure 37. World Primary CD56+ NK Cells Production Value Market Share by Type (2018-2029)
Figure 38. World Primary CD56+ NK Cells Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Primary CD56+ NK Cells Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Primary CD56+ NK Cells Production Value Market Share by Application in 2022
Figure 41. Compound Screening
Figure 42. Immune Function Assay
Figure 43. Drug Discovery
Figure 44. Others
Figure 45. World Primary CD56+ NK Cells Production Market Share by Application (2018-2029)
Figure 46. World Primary CD56+ NK Cells Production Value Market Share by Application (2018-2029)
Figure 47. World Primary CD56+ NK Cells Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Primary CD56+ NK Cells Industry Chain
Figure 49. Primary CD56+ NK Cells Procurement Model
Figure 50. Primary CD56+ NK Cells Sales Model
Figure 51. Primary CD56+ NK Cells Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
